Stanley Jordan, MD
Cedars-Sinai Medical Center · Cedars-Sinai Medical Center Comprehensive Transplant Center · Department of Pediatrics, Cedars-Sinai Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stanley Jordan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06919003 · Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)National Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Kidney Transplant · study chair
- Ph1/Ph2NCT03380377 · Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney TransplantStanley Jordan, MD · completed · Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy · principal investigator
- Ph1/Ph2NCT03380962 · Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal TransplantStanley Jordan, MD · completed · Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy · principal investigator
- Ph1/Ph2NCT01594424 · A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney TransplantationCedars-Sinai Medical Center · completed · End Stage Renal Disease (ESRD) · principal investigator
- Ph1/Ph2NCT01178216 · Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney TransplantationStanley Jordan, MD · completed · End Stage Renal Disease · principal investigator
- Ph3NCT00000935 · An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant AntigensNational Institute of Allergy and Infectious Diseases (NIAID) · completed · End-Stage Renal Disease, Kidney Transplantation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.